Form 4: Cigna CEO Cordani Buys Shares, Adjusts Trust Holdings

Cigna Group's Chairman and CEO, David Cordani, reported a purchase of 4,134 common shares and significant transfers related to his grantor retained annuity trust.

Summary

• David Cordani, Chairman & CEO of Cigna Group (CI), reported changes in his beneficial ownership of company common stock.
• On November 3, 2025, Cordani purchased 4,134 shares of Cigna common stock at a weighted average price of $241.8762 per share.
• The prices paid for these shares ranged from $241.876 to $241.97 per share.
• On June 9, 2025, 165,575 shares of common stock were transferred from Cordani's grantor retained annuity trust (GRAT) to him as an annual annuity payment.
• On August 4, 2025, Cordani transferred 271,986 shares of common stock to his grantor retained annuity trust (GRAT).
• Cordani also acquired shares through ongoing participation in The Cigna Group's 401(k) Plan.
• Following these transactions, Cordani beneficially owns 21,356 shares directly, 157,935 shares indirectly through a trust, 440,798 shares indirectly through a GRAT, and 1,782.7866 shares indirectly through a 401(k) Plan.

Sentiment

Score: 7

Explanation: The CEO's purchase of company stock is a positive signal, indicating confidence in the company's valuation and future prospects. The GRAT transfers are routine estate planning and do not significantly impact sentiment.

Positives

• The Chairman and CEO's direct purchase of 4,134 shares at $241.8762 indicates confidence in Cigna Group's future prospects.
• Insider buying can signal to the market that management believes the stock is undervalued or expects positive developments.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This filing reports an insider transaction by Cigna's CEO, which is a routine disclosure for publicly traded companies. It does not provide broader industry trends or competitive analysis.

Related Party Transactions

• Transfers of 165,575 shares from and 271,986 shares to the Reporting Person's grantor retained annuity trust (GRAT) are disclosed. These are common estate planning vehicles for executives.

Stakeholder Impact

• Shareholders may view the CEO's stock purchase as a sign of management confidence, potentially boosting investor sentiment.
• The transactions related to the grantor retained annuity trust are primarily for personal estate planning and have minimal direct impact on other stakeholders.

Key Dates

Recommendation

The Chairman and CEO's decision to purchase additional shares of Cigna Group common stock at the current market price suggests strong insider confidence in the company's valuation and future performance. This insider buying activity, especially from a top executive, often precedes positive developments or indicates a belief that the stock is undervalued, making it a favorable signal for potential investors.

Keywords

Cigna, CI, David Cordani, Insider Trading, Stock Purchase, CEO, Form 4, Beneficial Ownership, GRAT, 401(k)